Aller au contenu principal
Profil bibliographique

Jeanette Cu Yu

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées
287Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Sarcoma Diagnosis and TreatmentVascular Tumors and AngiosarcomasHepatocellular Carcinoma Treatment and PrognosisLymphoma Diagnosis and TreatmentViral-associated cancers and disorders

Les publications récentes

2022 conference-abstract OpenAlex

Prolonged disease control with pazopanib following radiation of primary tumor for locally advanced and metastatic soft tissue sarcoma.

Minggui Pan, Jeanette Cu Yu, Manpreet K. Sidhu

e23563 Background: Pazopanib is approved for second or later line therapy for advanced soft tissue sarcoma (STS). Whether or not Pazopanib and radiation have cooperative effect remains unclear. Methods: We retrospectively reviewed 10 patients with locally advanced or metastatic soft tissue sarcoma …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology
2022 conference-abstract OpenAlex

Clinical benefit of imatinib in patients with relapsed tenosynovial giant cell tumor/pigmented villonodular synovitis (TGCT/PVNS).

Jeanette Cu Yu, Manpreet K. Sidhu, Andrew S. Fang, Lee Jae Morse et autres

e23561 Background: TGCT/PVNS is an uncommon benign but locally aggressive tumor that affects joints and can lead to significant morbidity. It is characterized in most cases by a t(1;2) translocation that leads to overexpression of colony-stimulating factor 1 (CSF-1) and the accumulation …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology
Accès ouvert 2021 article OpenAlex

Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma

Minggui Pan, Maily K. Trieu, Manpreet K. Sidhu, Jeanette Cu Yu et autres

Gemcitabine-docetaxel (G-D) combination is an effective chemotherapy for patients with advanced soft tissue and bone sarcoma, first developed with G administered on days 1 and 8, and D on day 8 every 21 days and later modified to be administered every 14 …

us (code pays fourni par la source)

6 citations Cancers
Accès ouvert 2021 article OpenAlex

Impact of a Virtual Multidisciplinary Sarcoma Case Conference on Treatment Plan and Survival in a Large Integrated Healthcare System

Minggui Pan, Jeanette Cu Yu, Manpreet K. Sidhu, Tiffany Seto et autres

PURPOSE: Quantifying the impact of a multidisciplinary cancer case conference on patient outcome and care quality remains challenging. PATIENTS AND METHODS: We prospectively investigated the impact of our virtual multidisciplinary sarcoma case conference (VMSCC) on treatment plan in patients presented to the …

us (code pays fourni par la source)

9 citations JCO Oncology Practice
2020 article OpenAlex

Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference

Minggui Pan, Tiffany Seto, Jeanette Cu Yu, Manpreet K. Sidhu et autres

PURPOSE: Management of soft tissue and bone sarcoma presents many challenges, both diagnostically and therapeutically, and requires multidisciplinary collaboration; however, such collaboration is often challenging to establish, especially in the community setting. We share our experiences of a virtual multidisciplinary sarcoma case …

us (code pays fourni par la source)

6 citations JCO Oncology Practice
2020 article OpenAlex

Feasibility and Value of Establishing a Community-Based Virtual Multidisciplinary Sarcoma Case Conference

Minggui Pan, Tiffany Seto, Jeanette Cu Yu, Manpreet K. Sidhu et autres

PURPOSE: Management of soft tissue and bone sarcoma presents many challenges, both diagnostically and therapeutically, and requires multidisciplinary collaboration; however, such collaboration is often challenging to establish, especially in the community setting. We share our experiences of a virtual multidisciplinary sarcoma case …

us (code pays fourni par la source)

4 citations JCO Oncology Practice
Accès ouvert 2019 article OpenAlex

Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California

Tiffany Seto, Mee-Na Song, Maily K. Trieu, Jeanette Cu Yu et autres

Background: Pazopanib was approved for advanced soft tissue sarcoma as a second- or third-line therapy based on the clinical trial “Pazopanib for metastatic soft-tissue sarcoma” (PALETTE). We hypothesized that the real-world experiences may be significantly different from the clinical trial results. Methods: …

us (code pays fourni par la source)

33 citations Medical Sciences
2016 conference-abstract OpenAlex

Improving care quality for patients with soft tissue and bone sarcoma by establishing a national virtual tumor board and electronic consultation platform.

Minggui Pan, Andrew S. Fang, Maihgan A. Kavanagh, Brian Kim et autres

211 Background: Bone and soft tissue sarcomas are relatively uncommon and their management is extremely complex requiring coordinated multidisciplinary expertise for optimal care. Because Kaiser Permanente operates across many geographic regions in the country, in-person tumor board is not practical. Methods: The …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology
Accès ouvert 2015 article OpenAlex

Survival among HIV-Infected and HIV-Uninfected Individuals with Common Non–AIDS-Defining Cancers

Julia L. Marcus, Chun Chao, Wendy A. Leyden, Lanfang Xu et autres

BACKGROUND: Non-AIDS-defining cancers increasingly contribute to mortality among human immunodeficiency virus (HIV)-infected individuals. However, few studies have compared cancer prognosis by HIV status with adjustment for risk factors. METHODS: We conducted a cohort study of HIV-infected and HIV-uninfected adults in Kaiser Permanente …

us (code pays fourni par la source)

126 citations Cancer Epidemiology Biomarkers & Prevention
Accès ouvert 2012 article OpenAlex

Clinical Monitoring in a Patient With Friedreich Ataxia and Osteogenic Sarcoma

Eric C Deutsch, Lauren A. Seyer, Susan Perlman, Jeanette Cu Yu et autres

Friedreich ataxia is an autosomal recessive neurodegenerative disorder caused by mutations in the FXN gene that result in abnormally low levels of the mitochondrial protein frataxin. The authors recently used a lateral flow immunoassay to measure frataxin levels in a large cohort …

us (code pays fourni par la source)

5 citations Journal of Child Neurology
Accès ouvert 2010 article OpenAlex

Obesity and Microvascular Invasion in Hepatocellular Carcinoma

Abby B. Siegel, Shuang Wang, Judith S. Jacobson, Dawn L. Hershman et autres

BACKGROUND: We hypothesized that hepatocellular carcinoma (HCC) patients with higher Body Mass Index (BMI) might have more microvascular invasion (MVI) in their tumors. METHODS: Records from 138 consecutive patients who underwent surgery at Columbia University Medical Center from January 1, 2002 to …

us (code pays fourni par la source)

28 citations Cancer Investigation
Accès ouvert 2010 article OpenAlex

Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma

Jeanette Cu Yu, Alfred I. Neugut, Shuang Wang, Judith S. Jacobson et autres

BACKGROUND: : Patients with hepatocellular carcinoma (HCC) have a poor prognosis if their tumors are not diagnosed early. The authors investigated factors associated with the receipt of liver transplant among patients with HCC and evaluated the effects of these differences on survival. …

us (code pays fourni par la source)

65 citations Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.